Home
HelpTest Code CDTA Carbohydrate Deficient Transferrin, Adult, Serum
Reporting Name
Carb Def Transferrin, Adult, SUseful For
Indicating chronic alcohol abuse
This test is not appropriate for screening patients for congenital disorders of glycosylation.
Performing Laboratory
Mayo Clinic Laboratories in Rochester
Specimen Type
SerumOrdering Guidance
This test is for evaluation of alcohol abuse. If the ordering physician is looking for congenital disorders of glycosylation, order CDG / Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation, Serum.
Necessary Information
1. Patient's age is required.
2. Reason for testing is required if patient is younger than 21 years.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
0.05 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum | Frozen (preferred) | 45 days | |
| Refrigerated | 28 days | ||
| Ambient | 7 days |
Reference Values
≤0.10
0.11-0.12 (indeterminate)
Day(s) Performed
Wednesday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82373
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| CDTA | Carb Def Transferrin, Adult, S | 53803-3 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 31714 | Mono-oligo/Di-oligo Ratio | 35469-6 |
| 31715 | Interpretation | 59462-2 |
Interpretation
Patients with chronic alcoholism may develop abnormally glycosylated transferrin isoforms (ie, carbohydrate deficient transferrin: CDT >0.12). CDT results from 0.11 to 0.12 are considered indeterminate.
Patients with liver disease due to genetic or nongenetic causes may also have abnormal results.
Clinical Reference
1. De Giovanni N, Cittadini F, Martello S. The usefulness of biomarkers of alcohol abuse in hair and serum carbohydrate-deficient transferrin: a case report. Drug Test Anal. 2015;7(8):703-707
2. Fleming MF, Anton RF, Spies CD. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res. 2004;28(9):1347-1355
3. Gough G, Heathers L, Puckett D, et al. The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice. Alcohol Clin Exp Res. 2015;39(8):1493-1500
4. Shibamoto A, Namisaki T, Suzuki J, et al. Clinical significance of gamma-glutamyltranspeptidase combined with carbohydrate-deficient transferrin for the assessment of excessive alcohol consumption in patients with alcoholic cirrhosis. Medicines (Basel). 2021;8(7):39
5. Torrente MP, Freeman WM, Vrana KE. Protein biomarkers of alcohol abuse. Expert Rev Proteomics. 2012;9(4):425-436
Report Available
3 to 9 daysMethod Name
Affinity Chromatography/Mass Spectrometry (MS)
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.